1. GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: Evidence from high-throughput sequencing
   Chuanhui Chen et al, 2024, Translational Oncology CrossRef
2. MicroRNA-4458 suppresses the proliferation of human lung cancer cells in vitro by directly targeting Lin28B
   Chang-hong Liu et al, 2017, Acta Pharmacologica Sinica CrossRef
3. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3
   Yu Wang et al, 2017, Molecular Medicine Reports CrossRef
4. miR‑4458 directly targets IGF1R to inhibit cell proliferation and promote apoptosis in hemangioma
   Maosong Wu et al, 2020, Experimental and Therapeutic Medicine CrossRef
5. The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer
   Ritu Yadav et al, 2024, Cell Death Discovery CrossRef
6. MiR-4458/human antigen R (HuR) modulates PBX3 mRNA stability in melanoma tumorigenesis
   Henghua Zhou et al, 2020, Archives of Dermatological Research CrossRef
7. Circular RNA PRMT5 confers cisplatin‐resistance via miR‐4458/REV3L axis in non‐small‐cell lung cancer
   Jun Pang et al, 2020, Cell Biology International CrossRef
8. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4
   Jianrong Wu et al, 2019, Biochemistry and Cell Biology CrossRef
9. miR‐4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple‐negative breast cancer
   Xiaomeng Liu et al, 2019, Journal of Cellular Biochemistry CrossRef
10. Radix Tetrastigma Hemsleyani Flavone Inhibits the Occurrence and Development of Ovarian Cancer Cells by Regulating miRNA-4458 Expression
    Ping Liu et al, 2021, Journal of Biomaterials and Tissue Engineering CrossRef
11. MicroRNA-4458 Regulates PD-L1 Expression to Enhance Anti-tumor Immunity in NSCLC via Targeting STAT3
    Weixin Liu et al, 2021, Molecular Biotechnology CrossRef
12. MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer
    Jie Liu et al, 2022, Biomaterials Science CrossRef